Researchers identify mitochondrial calcium as a molecular switch regulating fat burning

Researchers have uncovered a previously unrecognized cellular mechanism that determines how the body mobilizes stored fat for energy. The findings, published in The EMBO Journal, show that calcium levels within mitochondria function as a molecular switch that regulates fat utilization by controlling the interaction between mitochondria and lipid droplets. The discovery provides new insights into energy metabolism and identifies potential therapeutic targets for obesity and metabolic disorders. 

In metabolically active tissues such as brown adipose tissue, mitochondria and lipid droplets work closely together to maintain energy homeostasis and support thermogenesis, the process by which the body generates heat through energy expenditure. The study demonstrates that the amount of calcium accumulated inside mitochondria determines whether these organelles remain attached to lipid droplets or detach from them. Under normal conditions, mitochondria physically interact with lipid droplets to help regulate energy storage. However, when mitochondrial calcium levels rise, structural changes occur within the mitochondria, causing them to separate from the lipid droplets. 

According to the researchers, this detachment represents a critical initiating event in fat metabolism. Once the mitochondria detach, lipases, the enzymes responsible for breaking down stored triglycerides, gain access to lipid droplets and initiate lipolysis, releasing fatty acids that can then be transported to mitochondria for oxidation and energy production.  The investigators found that mitochondrial detachment consistently occurs before lipolysis begins, indicating that it functions as a molecular trigger rather than a consequence of fat breakdown. 

The research team further identified the key molecular regulators governing this process. A mitochondrial sodium-calcium exchanger known as NCLX (mitochondrial Na⁺/Ca²⁺ exchanger) plays a central role by controlling calcium efflux from mitochondria. Reduced NCLX activity causes calcium to accumulate within mitochondria, promoting their detachment from lipid droplets and facilitating fat mobilization. In contrast, active NCLX maintains lower mitochondrial calcium levels, preserving the physical association between mitochondria and lipid droplets and limiting the access of lipases to stored fat. 

The investigators also identified phosphodiesterase 2A (PDE2A) as an upstream regulator of this pathway. PDE2A indirectly influences mitochondrial calcium homeostasis by modulating intracellular cyclic nucleotide signaling, thereby affecting the interaction between mitochondria and lipid droplets. Through this mechanism, PDE2A helps coordinate cellular decisions regarding whether energy is derived from stored fat or from alternative metabolic fuels. 

To explore the therapeutic implications of these findings, the researchers evaluated the pathway in animal models of obesity. Pharmacological inhibition of PDE2A altered the interaction between mitochondria and lipid droplets, reduced excessive fat breakdown, and shifted cellular energy production toward greater glucose utilization. This metabolic reprogramming improved overall energy balance and increased metabolic expenditure, suggesting that modulation of mitochondrial calcium signaling could offer a novel strategy for treating metabolic diseases. 

The study highlights the importance of communication between cellular organelles in regulating energy metabolism. Rather than functioning as isolated structures, mitochondria and lipid droplets continuously coordinate their interactions in response to metabolic demands, with mitochondrial calcium acting as a key regulator of this dynamic process. 

The authors believe that these findings significantly advance the understanding of how cells control energy utilization and maintain metabolic homeostasis. By identifying mitochondrial calcium signaling, NCLX, and PDE2A as critical regulators of fat mobilization, the study opens new avenues for the development of targeted therapies aimed at obesity, type 2 diabetes, and other metabolic disorders in which impaired energy metabolism contributes to disease progression. 

 

References 

  1. Acin-Perez R, Assali EA, Veliova M, Ngo J, Brownstein AJ, Villalobos F, et al. Mitochondrial calcium regulates lipid metabolism by modulating tethering of mitochondria to lipid droplets. EMBO J. 2026. 

 

Don’t miss our updates!

We don’t spam! Read our [link]privacy policy[/link] for more info.

Leave a Reply